Among 94 matched-pairs of clinic samples (T and N), SPON2 mRNA expression was also significantly higher (1.70-fold) in ccRCC tissues than that in the adjacent normal tissues (P < 0.001). The gene discussed is SPON2; the disease is nonpapillary renal cell carcinoma.